The Development and Evaluation of State of the Art Prognostication in a Novel Palliative Care Program for Patients with Advanced Chronic Kidney Disease in Canada

加拿大晚期慢性肾病患者新型姑息治疗计划中最先进预测的开发和评估

基本信息

  • 批准号:
    266267
  • 负责人:
  • 金额:
    $ 24.91万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Operating Grants
  • 财政年份:
    2012
  • 资助国家:
    加拿大
  • 起止时间:
    2012-09-01 至 2016-09-01
  • 项目状态:
    已结题

项目摘要

Palliative care has historically focused on advanced cancer. However, people with advanced non-cancer conditions also need excellent end of life care. We have shown that patients dying with advanced chronic kidney disease (CKD) have extensive end-of-lif
姑息治疗历来专注于晚期癌症。然而,患有晚期非癌症疾病的人也需要出色的临终关怀。我们已经证明,死于晚期慢性肾脏病(CKD)的患者有广泛的生命末期。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Davison Sara其他文献

Davison Sara的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Davison Sara', 18)}}的其他基金

Development, Implementation and Evaluation of an Innovative Integrated Supportive Care Pathway by Primary Care across Alberta
艾伯塔省初级保健创新综合支持性护理途径的开发、实施和评估
  • 批准号:
    405780
  • 财政年份:
    2019
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Operating Grants
Development, Implementation and Evaluation of an Innovative Integrated Supportive Care Pathway by Primary Care across Alberta
艾伯塔省初级保健创新综合支持性护理途径的开发、实施和评估
  • 批准号:
    378844
  • 财政年份:
    2018
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Operating Grants
Implementation and Evaluation of an Innovative Integrated Conservative (Non-Dialysis) Kidney Management (CKM) Pathway by Primary Care Across Alberta.
艾伯塔省初级保健创新综合保守(非透析)肾脏管理 (CKM) 途径的实施和评估。
  • 批准号:
    372367
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Operating Grants
Development, Implementation and Evaluation of an Innovative Integrated Supportive Care Pathway by Primary Care across Alberta
艾伯塔省初级保健创新综合支持性护理途径的开发、实施和评估
  • 批准号:
    378749
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Miscellaneous Programs
Improving Global End-of-Life Care Outcomes for Patients with Advanced Chronic Kidney Disease
改善全球晚期慢性肾病患者的临终护理结果
  • 批准号:
    256652
  • 财政年份:
    2012
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Miscellaneous Programs
Functional and Symptom Trajectories in Elderly Chronic Kidney Disease Patients and their Association with Dialysis Initiation
老年慢性肾病患者的功能和症状轨迹及其与透析启动的关系
  • 批准号:
    266239
  • 财政年份:
    2012
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Operating Grants

相似海外基金

Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
  • 批准号:
    10092585
  • 财政年份:
    2024
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Collaborative R&D
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
  • 批准号:
    10676628
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease
血红素介导的线粒体损伤、衰老、急性肾损伤和慢性肾病
  • 批准号:
    10656648
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
The Role of Patient Capacity in Chronic Kidney Disease Trajectories
患者能力在慢性肾脏病轨迹中的作用
  • 批准号:
    10737920
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Mitigating the Effects of Structural Racism on Chronic Kidney Disease Disparities among African Americans
减轻结构性种族主义对非裔美国人慢性肾病差异的影响
  • 批准号:
    10742680
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
患有慢性肾病的男性的抗苗勒氏管激素和心血管风险:一个方案。
  • 批准号:
    481028
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Effects of HIF-PHD inhibitors on copper metabolism and association with organ damage in chronic kidney disease.
HIF-PHD 抑制剂对铜代谢的影响及其与慢性肾脏病器官损伤的关系。
  • 批准号:
    23K15258
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
  • 批准号:
    10648527
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
  • 批准号:
    10638267
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Mechanisms of Mitochondrial Metabolic Dysfunction in Chronic Kidney Disease
慢性肾脏病线粒体代谢功能障碍的机制
  • 批准号:
    10862480
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了